Orion Capital Management’s Palisade Bio PALI Stock Holding History
Bought
Maintained
Sold
Other funds holding PALI
MG
AC
TRCT
FDCDDQ
Orion Capital Management's PALI Position: Q2 2024 in Review
Orion Capital Management sold out of Palisade Bio (PALI) in Q2 2024, closing a stake of 20 shares — an estimated $119 sold.
Orion Capital Management first reported a position in PALI in Q1 2023 and held it in 4 quarters. The position peaked at $1.05K in Q1 2023. 8 funds tracked by Wall St. Rank hold PALI as of Q2 2024.
- Orion Capital Management reported no remaining Palisade Bio position as of Q2 2024 after selling out during the quarter.
- Orion Capital Management sold 20 Palisade Bio shares in Q2 2024, an estimated $119.
- Orion Capital Management first reported a position in Palisade Bio in Q1 2023 and held it in 4 quarters.
- Orion Capital Management's Palisade Bio position peaked at $1.05K in Q1 2023.
- 8 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2024.
Based on Orion Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.